Lorena Bernal Rubio

Platinum and Taxane Hypersensitivity: Description of Immunological Phenotypes and Search for Biomarkers to Optimize Diagnosis and Treatment

Study of the immunological and epigenetic mechanisms associated with the efficacy of SLIT Pru p3 immunotherapy in patients allergic to peach and other nsLTPs

Multicenter retrospective observational study to evaluate the tolerability of subcutaneous immunotherapy with major allergen Cupressus arizonica (Cup a1) in patients with allergic rhinoconjunctivitis (with or without controlled asthma)

STUDY ON THE BURDEN THAT REFRACTORY OR UNEXPLAINED CHRONIC COUGH PLACES ON THE HEALTH SYSTEM AND PATIENTS

A phase 3b Randomized Double-blind, Placebo controlled, multicenter study to evaluate the efficacy and safety of Gefapixant in adult participants with recent onset chronic cough

Multicenter, double-blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of immunotherapy with the purified major allergen Cup a1 in patients with moderate/severe rhinoconjunctivitis (with or without controlled asthma and sensitization to cypress trees)

EO 20/418 - ALL-OLE-2020-01 Prospective observational study to evaluate the safety and effectiveness of olive and grass pollen allergoid immunotherapy in patients with seasonal allergic asthma (GOL Study)

Biological standardization of the allergenic extract of wild grass pollen (Phleum pratense, Lolium perenne, Poa pratensis, Dactylis glomerata and their mixture) to determine its activity in Histamine equivalent units (HEP) in sensitized patients

SL-51A. PHASE II STUDY TO ASSESS THE TOLERABILITY, SAFETY AND EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN PATIENTS SUFFERING FROM GRASS POLLEN ALLERGY